|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, October 18, 2017 ) Cell Counting Market in America is quality cell health system, increased importance of cell counting and wide range of cell counting applications. Cell counting is one of the method for the counting the cells in the life sciences, including medical diagnosis and treatment. It is an important subset of cytometry, with applications in research and clinical practice. It is an important process in the field of life sciences, including medical diagnosis and treatment and biological research. The American market for cell counting is expected to reach USD 10.5 billion in 2023 from USD 6.3 billion in 2016 with a CAGR of approximately 14.9%.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/578 .
For researchers, cell counting is a major step in most experimental workflows, helping them to maintain cell cultures, prepare cells for transfection and downstream experiments. Researchers often need to count cells prior to cell culture or before studying downstream processes and using analytical techniques that require an accurate number of input cells.
Furthermore, growing out of pocket expenditure and use of enhanced data visualization and analysis software led to market growth.
Competitor Companies for Cell Counting Market:
Bio-Rad Laboratories Inc. (U.S), General Electric Company (U.S), Agilent Technologies (U.S), PerkinElmer Inc. (U.S), Tecan Trading AG (Switzerland), BioTek Instruments, Inc. (U.S), Danaher (U.S), Merck KGaA (U.S)
Browse Report @ https://www.marketresearchfuture.com/reports/americas-cell-counting-market .
Market Segmentation:
The American cell counting market is segmented on the basis on instruments used for cell counting which are spectrophotometer, cell counter, hemocytometer, flow cytometer, hematology analyzer, microscope and other instruments. On the basis of application of cell counting which includes cell structure study and cell analysis, quality control, cell viability, proliferation, signaling, identification, single cell analysis and other applications. It is also segmented on the basis of its end users which are hospitals, research institutes, pharmaceutical and biotechnology companies, clinical research organizations and other end users.
Regional Analysis of Cell Counting Market:
On the basis of region Americas market is divided into North America, and South America. North America consists of U.S, Canada, Mexico and Rest of North America. North America is the largest market for cell counting which is expected to grow at a CAGR of 9.3% and is expected to reach at US$ 5.4 billion. This is due to presence of prominent cell counting market players, rising prevalence of chronic diseases and highly developed healthcare system. The U.S. accounts for the largest market for cell counting in North America.
South America is second largest market for cell counting whose growth is driven by improved diagnosis and treatment methods favor the rising demand of this market. Improved technology in the manufacturing of cell counting instruments further enhance the growth of this market.
Get Discount @ https://www.marketresearchfuture.com/check-discount/578 .
Marketresearchfuture
Market Research Future
+1 (646) 845 9349
sales@wiseguyreports.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
